EMFO LLC’s Clovis Oncology, Inc. CLVS Stock Holding History

EMFO LLC’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-16,000	Closed	-$19K	–	328
2022 Q3	$19K	Sell	16,000 -2,000	-11%	-$3.12K	0.02%	223
2022 Q2	$32K	Sell	18,000 -3,500	-16%	-$5.16K	0.03%	200
2022 Q1	$43K	Hold	21,500	–	–	0.04%	198
2021 Q4	$58K	Sell	21,500 -24,000	-53%	-$88.7K	0.05%	190
2021 Q3	$203K	Hold	45,500	–	–	0.18%	103
2021 Q2	$264K	Buy	+45,500	New	+$267K	0.23%	83

Other funds holding CLVS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

CAS

Coppell Advisory Solutions Coppell, Texas $170M AUM 13.42% 1-Year Est. Return

CASC

Coppell Advisory Solutions Corp Coppell, Texas $531M AUM

STB

S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return

MCM

MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

FFWM

Future Financial Wealth Management Cincinnati, Ohio $155M AUM 13% 1-Year Est. Return

NFSG

Newbridge Financial Services Group Boca Raton, Florida $608M AUM 31.28% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

EMFO LLC's CLVS Position: Q4 2022 in Review

EMFO LLC sold out of Clovis Oncology, Inc. (CLVS) in Q4 2022, closing a stake of 16,000 shares — an estimated $19K sold.

EMFO LLC first reported a position in CLVS in Q2 2021 and held it in 6 quarters. The position peaked at $264K in Q2 2021. 15 funds tracked by Wall St. Rank hold CLVS as of Q4 2022.

EMFO LLC reported no remaining Clovis Oncology, Inc. position as of Q4 2022 after selling out during the quarter.
EMFO LLC sold 16,000 Clovis Oncology, Inc. shares in Q4 2022, an estimated $19K.
EMFO LLC first reported a position in Clovis Oncology, Inc. in Q2 2021 and held it in 6 quarters.
EMFO LLC's Clovis Oncology, Inc. position peaked at $264K in Q2 2021.
15 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2022.

Based on EMFO LLC's 13F filing for Q4 2022, filed 2 Feb 2023.